Controlled release oral dosage form

Details Controlled release oral dosage form Controlled release oral dosage form

2005-06-14

2005-06-14

Spear, James M. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S490000, C424S457000, C424S458000

Reexamination Certificate

active

06905708

ABSTRACT:
A once a day bupropion hydrochloride formulation is disclosed

REFERENCES:
patent: 2987445 (1961-06-01), Levesque
patent: 3146169 (1964-08-01), Stephenson et al.
patent: 3538214 (1970-11-01), Polli et al.
patent: 3773920 (1973-11-01), Nakamoto et al.
patent: 3819706 (1974-06-01), Mehta
patent: 3885046 (1975-05-01), Mehta
patent: 4016880 (1977-04-01), Theeuwes et al.
patent: 4135514 (1979-01-01), Zaffaroni et al.
patent: 4173626 (1979-11-01), Dempski et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4393078 (1983-07-01), Peck
patent: 4435449 (1984-03-01), Stern
patent: 4438138 (1984-03-01), Stern
patent: 4507323 (1985-03-01), Stern
patent: 4519801 (1985-05-01), Edgren
patent: 4539198 (1985-09-01), Powell et al.
patent: 4557925 (1985-12-01), Lindahl et al.
patent: 4571395 (1986-02-01), Peck
patent: 4687660 (1987-08-01), Baker et al.
patent: 5098715 (1992-03-01), McCabe et al.
patent: RE33994 (1992-07-01), Baker et al.
patent: 5358970 (1994-10-01), Ruff et al.
patent: 5427798 (1995-06-01), Ludwig et al.
patent: 5472708 (1995-12-01), Chen
patent: 5478577 (1995-12-01), Sackler et al.
patent: 5508040 (1996-04-01), Chen
patent: 5508042 (1996-04-01), Oshlack et al.
patent: 5512593 (1996-04-01), Dante
patent: 5541231 (1996-07-01), Ruff et al.
patent: 5672360 (1997-09-01), Sackler et al.
patent: 5731000 (1998-03-01), Ruff et al.
patent: 5763493 (1998-06-01), Ruff et al.
patent: 5837379 (1998-11-01), Chen et al.
patent: 5968553 (1999-10-01), Maitra et al.
patent: 5990175 (1999-11-01), Pinsker
patent: 6033686 (2000-03-01), Seth
patent: 6096341 (2000-08-01), Seth
patent: 6110973 (2000-08-01), Young
patent: 6143327 (2000-11-01), Seth
patent: 6150420 (2000-11-01), Houdi et al.
patent: 6194002 (2001-02-01), Sherman
patent: 6197827 (2001-03-01), Cary
patent: 6210716 (2001-04-01), Chen et al.
patent: 6221917 (2001-04-01), Maitra et al.
patent: 6238697 (2001-05-01), Kumar et al.
patent: 6242496 (2001-06-01), Kulkarni et al.
patent: 6277887 (2001-08-01), Young
patent: 6280763 (2001-08-01), Midha et al.
patent: 6306436 (2001-10-01), Chungi et al.
patent: 6312716 (2001-11-01), Midha et al.
patent: 6333332 (2001-12-01), Han et al.
patent: 6337328 (2002-01-01), Fang et al.
patent: 6342496 (2002-01-01), Jerussi et al.
patent: 6369113 (2002-04-01), Young
patent: 6589553 (2003-07-01), Li et al.
patent: WO 00/30685 (2000-06-01), None
Physicians' Desk Reference 46th Edition 1992 p. 821 “Wellbutrin”.
Cooper et al., Journal of Pharmaceutical Sciences, vol. 73, No. 8 Aug. 1984; “Determination of Bupropion and Its Major Basic Metabolites in Plasma by Liquid Chromatography with Dual-Wave Ultraviolet Detection” pp. 1104-1107.

Affiliated with

Also associated with

Rating

Controlled release oral dosage form does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release oral dosage form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oral dosage form will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3490120